SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-22-007537
Filing Date
2022-03-25
Accepted
2022-03-25 16:13:11
Documents
2
Period of Report
2022-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1769
2 poa_arenberg.htm EX-24 8924
  Complete submission text file 0001567619-22-007537.txt   12032
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 (415) 529-5055
Imago BioSciences, Inc. (Issuer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address
Arenberg Michael (Reporting) CIK: 0001755509 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40604 | Film No.: 22771508